#WestChinaHospital Archives

ASCO-GU Interview | Dr. Yige Bao Shares Progress in PARPi Precision Treatment of Prostate Cancer and His Team’s Research on Neoadjuvant Therapy for UTUC

By Mourabit Halima 2024.03.07

Editor's Note: The annual American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO-GU) was recently held in San Francisco, USA. Over its twenty-year history, the ASCO-GU Symposium has witnessed the…

Daratumumab-based immunotherapy vs. lenalidomide, bortezomib and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: a systemic review

By Mourabit Halima 2024.03.07

In January 2024, a study led by Professor Ting Niu from West China Hospital, Sichuan University was published in the international academic journal ——Frontiers In Oncology. The title of the…

ASCO-GU Interview | Dr. Pengfei Shen Interprets PROpel Study, Shares Genetic Testing to Guide Precise Treatment of Prostate Cancer

By Mourabit Halima 2024.03.04

Editor's Note: Following the breakthrough of the PROfound study, which marked the beginning of precision treatment for prostate cancer, the PROpel study has further extended the application of PARP inhibitors…